Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.34 |
| ▸ | RXRA | P19793 | 6/20 | 0.34 |
| ▸ | RARA | P10276 | 6/20 | 0.34 |
| ▸ | RARB | P10826 | 6/20 | 0.34 |
| ▸ | RARG | P13631 | 6/20 | 0.34 |
| ▸ | MAPT | P10636 | 4/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.34 |
| ▸ | RXRB | P28702 | 3/20 | 0.34 |
| ▸ | RXRG | P48443 | 3/20 | 0.34 |
| ▸ | RORC | P51449 | 2/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | HTR2B | P41595 | 2/20 | 0.34 |
| ▸ | BLM | P54132 | 2/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.34 |
| ▸ | APP | P05067 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3249788 | 0.85 | CYP1A2 (0.41) | CYP1A2ALDH1A1TDP1HAO1RXRA | |
| SCHEMBL9959984 | 0.83 | CYP1A2 (0.43) | CYP1A2ALDH1A1HAO1RXRARARA | |
| SCHEMBL31305881 | 0.77 | CYP1A2 (0.36) | CYP1A2ALDH1A1TDP1HAO1 | |
| SCHEMBL11563975 | 0.76 | CYP1A2 (0.41) | CYP1A2ALDH1A1TDP1HAO1RXRA | |
| SCHEMBL11482058 | 0.73 | CYP1A2 (0.36) | CYP1A2ALDH1A1TDP1HAO1RXRA | |
| SCHEMBL12813290 | 0.71 | NPC1 (0.40) | ALDH1A1TDP1RXRARARARARB | |
| SCHEMBL1782075 | 0.71 | CYP1A2 (0.47) | CYP1A2ALDH1A1TDP1HAO1RXRA | |
| SCHEMBL11493728 | 0.71 | CYP1A2 (0.34) | CYP1A2ALDH1A1TDP1HAO1RXRA | |
| SCHEMBL10946665 | 0.70 | GRIK1 (0.34) | CYP1A2HAO1RXRAGRIK1GRIK2 | |
| SCHEMBL11498563 | 0.70 | CYP1A2 (0.33) | CYP1A2ALDH1A1TDP1HAO1RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2046708-A2 | PROCESS FOR EPIMERISING CYCLOHEXENYL KETONES AND ITS APPLICATION IN ALDOL CONDENSATION PROCESS | The Procter and Gamble Company (US) | 2009-04-15 | — | — | EP | claimed |
| US-7414158-B2 | Process for epimerising cyclohexenyl ketones and its application in Aldol condensation process | THE PROCTER & GAMBLE COMPANY (US) | 2008-08-19 | — | — | US | claimed |
| WO-2008012758-A2 | PROCESS FOR EPIMERISING CYCLOHEXENYL KETONES AND ITS APPLICATION IN ALDOL CONDENSATION PROCESS | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-31 | — | — | WO | claimed |
| US-20080021246-A1 | Process for epimerising cyclohexenyl ketones and its application in aldol condensation process | PROCTER & GAMBLE COMPANY, THE | 2008-01-24 | — | — | US | claimed |
| EP-2046708-A2 | PROCESS FOR EPIMERISING CYCLOHEXENYL KETONES AND ITS APPLICATION IN ALDOL CONDENSATION PROCESS | The Procter and Gamble Company (US) | 2009-04-15 | — | — | EP | disclosed |
| US-7414158-B2 | Process for epimerising cyclohexenyl ketones and its application in Aldol condensation process | THE PROCTER & GAMBLE COMPANY (US) | 2008-08-19 | — | — | US | disclosed |
| WO-2008012758-A2 | PROCESS FOR EPIMERISING CYCLOHEXENYL KETONES AND ITS APPLICATION IN ALDOL CONDENSATION PROCESS | THE PROCTER & GAMBLE COMPANY (US) | 2008-01-31 | — | — | WO | disclosed |
| US-20080021246-A1 | Process for epimerising cyclohexenyl ketones and its application in aldol condensation process | PROCTER & GAMBLE COMPANY, THE | 2008-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021246-A1 | Process for epimerising cyclohexenyl ketones and its application in aldol condensation process | ALDOA, PCK1, HPD | CYP1A2 484/4885ALDH1A1 1349/4885TDP1 3729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.